NM_004260.4:c.1697T>C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_004260.4(RECQL4):c.1697T>C(p.Leu566Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,611,976 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152196Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000118 AC: 29AN: 246650Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134330
GnomAD4 exome AF: 0.000193 AC: 282AN: 1459662Hom.: 1 Cov.: 36 AF XY: 0.000209 AC XY: 152AN XY: 726032
GnomAD4 genome AF: 0.000190 AC: 29AN: 152314Hom.: 0 Cov.: 34 AF XY: 0.000201 AC XY: 15AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:2
PM3_supporting -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34869606, 27247962, 32191290, 31874108, 24728327) -
not specified Uncertain:1Other:1
Variant summary: RECQL4 c.1697T>C (p.Leu566Pro) results in a non-conservative amino acid change in the encoded protein sequence. Three of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 246650 control chromosomes (gnomAD). c.1697T>C has been reported in the literature in individuals affected with Rothmund-Thomson syndrome or osteosarcoma (Suter_2016, Mirabello_2020). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. The following publications have been ascertained in the context of this evaluation (PMID: 24728327, 33294214, 31874108, 32191290, 27247962, 34869606). All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
- -
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 566 of the RECQL4 protein (p.Leu566Pro). This variant is present in population databases (rs201648505, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of Rothmund–Thomson Syndrome (PMID: 27247962, 32191290). ClinVar contains an entry for this variant (Variation ID: 135129). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at